Nautilus Biotechnology, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
5.00
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
2
|
|
# Buys
|
0
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.18
|
0.00
|
0.18
|
100.00%
|
|
2022-12-31
|
-0.15
|
0.00
|
0.15
|
100.00%
|
|
2022-09-30
|
-0.15
|
-0.11
|
0.04
|
26.67%
|
|
2022-06-30
|
-0.17
|
-0.12
|
0.05
|
29.41%
|
|
2022-03-31
|
-0.16
|
-0.13
|
0.03
|
18.75%
|
|
2021-12-31
|
-0.13
|
-0.13
|
0.00
|
0.00%
|
|
2021-09-30
|
-0.10
|
-0.12
|
-0.02
|
-20.00%
|
|
2021-06-30
|
-0.07
|
-0.19
|
-0.12
|
-171.43%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.36
|
|
2021-12-31
|
-0.79
|
|
2020-12-31
|
-0.03
|